Don't have an account? Register here to gain unlimited access to The Medicine Maker.
12/28/2022 | Naiara Tejados, PhD | 5 min read
Everything you ever wanted to know (but were too afraid to ask) about in vivo and ex vivo lentiviral vector therapies
12/27/2022 | Brian Mullan | 12 min read
Great successes are being seen in gene therapy, but there are still gaps in our scientific knowledge – and our manufacturing prowess.
12/22/2022 | Angus Stewart | 4 min read
Why critical starting materials are crucial to the production of cell and gene therapies, and among them cord blood deserves particular attention
12/21/2022 | Angus Stewart | 7 min read
More than a few pearls of wisdom were dropped at this key gathering in London, and we were there to catch them.
12/13/2022 | Angus Stewart
In the face of economic uncertainty in a post-pandemic world, how will the cell and gene field respond?
12/07/2022 | Dalip Sethi | 7 min read
We all know that automation can reduce human labor, but how else can it make economically viable cell and gene therapies a reality?
12/06/2022 | Kevin Clifford | 4 min read
Genetic insights may offer shortcuts along the clinical development pathway, bringing new therapeutics to market faster
12/05/2022 | George Todorov | 17 min read
Demand for cell and gene therapies is increasing, but are current manufacturing approaches up to the task?
12/02/2022 | Rob Coker | 4 min read
CEO and Founder of EnteroBiotix James McIllroy shares the wonders of manipulating our microbial passengers.
11/30/2022 | Angus Stewart
Get a sharp perspective on the cell and gene status quo in The Medicine Maker 2022 supplement on advanced medicine
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
Understanding the H5N1 Threat
The Synergy of Science and Business
Building Culture, Driving Growth